Another study attributed chemerin to a protective mechanism, as it seemed to reduce placenta mitochondrial dysfunction in GDM patients, promoting the expression of disulfide-bond A oxidoreductase-like protein and inhibiting the cyclic GMP-AMP synthase stimulator of interferon genes pathway [72]. This evidence concerns the gene CGAS and gestational diabetes.